SHP(small heterodimer partner)もしくはNR0B2(nuclear receptor subfamily 0 group B member 2)は、ヒトではNR0B2遺伝子によってコードされているタンパク質である。SHPは核内受容体ファミリーに属するが、DNA結合ドメインを欠いているという点で例外的存在である。そのため厳密には転写因子でも核内受容体でもないが、核内受容体ファミリーの他のメンバーと比較的高い配列相同性を有するためこのファミリーに分類されている。
↑Lee HK, Lee YK, Park SH, Kim YS, Park SH, Lee JW, Kwon HB, Soh J, Moore DD, Choi HS(June 1998).“Structure and expression of the orphan nuclear receptor SHP gene”.The Journal of Biological Chemistry273(23): 14398–402.doi:10.1074/jbc.273.23.14398.PMID9603951.
↑Båvner A, Sanyal S, Gustafsson JA, Treuter E(December 2005).“Transcriptional corepression by SHP: molecular mechanisms and physiological consequences”.Trends in Endocrinology and Metabolism16(10): 478–88.doi:10.1016/j.tem.2005.10.005.PMID16275121.
↑Gobinet J, Auzou G, Nicolas JC, Sultan C, Jalaguier S(December 2001).“Characterization of the interaction between androgen receptor and a new transcriptional inhibitor, SHP”.Biochemistry40(50): 15369–77.doi:10.1021/bi011384o.PMID11735420.
↑Klinge CM, Jernigan SC, Risinger KE(March 2002).“The agonist activity of tamoxifen is inhibited by the short heterodimer partner orphan nuclear receptor in human endometrial cancer cells”.Endocrinology143(3): 853–67.doi:10.1210/endo.143.3.8676.PMID11861507.
123Brendel C, Schoonjans K, Botrugno OA, Treuter E, Auwerx J(September 2002).“The small heterodimer partner interacts with the liver X receptor alpha and represses its transcriptional activity”.Molecular Endocrinology16(9): 2065–76.doi:10.1210/me.2001-0194.PMID12198243.
↑Lee YK, Moore DD(January 2002).“Dual mechanisms for repression of the monomeric orphan receptor liver receptor homologous protein-1 by the orphan small heterodimer partner”.The Journal of Biological Chemistry277(4): 2463–7.doi:10.1074/jbc.M105161200.PMID11668176.
↑Nishizawa H, Yamagata K, Shimomura I, Takahashi M, Kuriyama H, Kishida K, Hotta K, Nagaretani H, Maeda N, Matsuda M, Kihara S, Nakamura T, Nishigori H, Tomura H, Moore DD, Takeda J, Funahashi T, Matsuzawa Y(January 2002).“Small heterodimer partner, an orphan nuclear receptor, augments peroxisome proliferator-activated receptor gamma transactivation”.The Journal of Biological Chemistry277(2): 1586–92.doi:10.1074/jbc.M104301200.PMID11696534.
↑Seol W, Hanstein B, Brown M, Moore DD(October 1998).“Inhibition of estrogen receptor action by the orphan receptor SHP (short heterodimer partner)”.Molecular Endocrinology12(10): 1551–7.doi:10.1210/me.12.10.1551.PMID9773978.
Seol W, Hanstein B, Brown M, Moore DD(October 1998).“Inhibition of estrogen receptor action by the orphan receptor SHP (short heterodimer partner)”.Molecular Endocrinology12(10): 1551–7.doi:10.1210/me.12.10.1551.PMID9773978.
Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, Mangelsdorf DJ(September 2000).“Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors”.Molecular Cell6(3): 507–15.doi:10.1016/S1097-2765(00)00050-2.PMID11030331.
Lee YK, Moore DD(January 2002).“Dual mechanisms for repression of the monomeric orphan receptor liver receptor homologous protein-1 by the orphan small heterodimer partner”.The Journal of Biological Chemistry277(4): 2463–7.doi:10.1074/jbc.M105161200.PMID11668176.
Nishizawa H, Yamagata K, Shimomura I, Takahashi M, Kuriyama H, Kishida K, Hotta K, Nagaretani H, Maeda N, Matsuda M, Kihara S, Nakamura T, Nishigori H, Tomura H, Moore DD, Takeda J, Funahashi T, Matsuzawa Y(January 2002).“Small heterodimer partner, an orphan nuclear receptor, augments peroxisome proliferator-activated receptor gamma transactivation”.The Journal of Biological Chemistry277(2): 1586–92.doi:10.1074/jbc.M104301200.PMID11696534.
Sanyal S, Kim JY, Kim HJ, Takeda J, Lee YK, Moore DD, Choi HS(January 2002).“Differential regulation of the orphan nuclear receptor small heterodimer partner (SHP) gene promoter by orphan nuclear receptor ERR isoforms”.The Journal of Biological Chemistry277(3): 1739–48.doi:10.1074/jbc.M106140200.PMID11705994.
Gobinet J, Auzou G, Nicolas JC, Sultan C, Jalaguier S(December 2001).“Characterization of the interaction between androgen receptor and a new transcriptional inhibitor, SHP”.Biochemistry40(50): 15369–77.doi:10.1021/bi011384o.PMID11735420.
Klinge CM, Jernigan SC, Risinger KE(March 2002).“The agonist activity of tamoxifen is inhibited by the short heterodimer partner orphan nuclear receptor in human endometrial cancer cells”.Endocrinology143(3): 853–67.doi:10.1210/endo.143.3.8676.PMID11861507.
Ogata M, Awaji T, Iwasaki N, Miyazaki S, Bell GI, Iwamoto Y(March 2002).“Nuclear translocation of SHP and visualization of interaction with HNF-4alpha in living cells”.Biochemical and Biophysical Research Communications292(1): 8–12.doi:10.1006/bbrc.2002.6593.PMID11890664.
Cao H, Hegele RA(2002).“Identification of polymorphisms in the human SHP1 gene”.Journal of Human Genetics47(8): 445–7.doi:10.1007/s100380200062.PMID12181644.
Brendel C, Schoonjans K, Botrugno OA, Treuter E, Auwerx J(September 2002).“The small heterodimer partner interacts with the liver X receptor alpha and represses its transcriptional activity”.Molecular Endocrinology16(9): 2065–76.doi:10.1210/me.2001-0194.PMID12198243.
Borgius LJ, Steffensen KR, Gustafsson JA, Treuter E(December 2002).“Glucocorticoid signaling is perturbed by the atypical orphan receptor and corepressor SHP”.The Journal of Biological Chemistry277(51): 49761–6.doi:10.1074/jbc.M205641200.PMID12324453.
Hung CC, Farooqi IS, Ong K, Luan J, Keogh JM, Pembrey M, Yeo GS, Dunger D, Wareham NJ, O' Rahilly S(May 2003).“Contribution of variants in the small heterodimer partner gene to birthweight, adiposity, and insulin levels: mutational analysis and association studies in multiple populations”.Diabetes52(5): 1288–91.doi:10.2337/diabetes.52.5.1288.PMID12716767.
Lai K, Harnish DC, Evans MJ(September 2003).“Estrogen receptor alpha regulates expression of the orphan receptor small heterodimer partner”.The Journal of Biological Chemistry278(38): 36418–29.doi:10.1074/jbc.M303913200.PMID12842887.
Kovacic A, Speed CJ, Simpson ER, Clyne CD(January 2004).“Inhibition of aromatase transcription via promoter II by short heterodimer partner in human preadipocytes”.Molecular Endocrinology18(1): 252–9.doi:10.1210/me.2003-0211.PMID14593077.